简介：为观察电针治疗椎间盘突出症疗程与疗效的关系及对改善椎间盘突出不同临床症状间的差别，根据症状表现仅有腰痛、腿痛及腰痛兼腿痛分为不同治疗组，每组治疗3个疗程。结果疗程与疗效有显著差别(P<0．01)；症状与疗效有差别(P<0．05)。电针治疗腰椎间盘突出临床症状改善，腰痛最明显，腿痛最差，且第2疗程疗效显著。

简介：Purpose:ToobservetheclinicaltherapeuticeffectofelectroacupunctureplusTuinaontreatingprolapseoflumbarintervertebraldisc.Methods:Electro-acupunctureatJiaji(Ex-B2)acupointsplusreductionmanipulationswereusedtotreat30casesofprolapseoflumbarintervertebraldisc.Results:After2coursesoftreatment,amongthe30cases,8caseswerecuredand22casesgotimprovements,andtheeffectiveratewas100%.Conclusion:Electroacupunctureplusreductionmanipula-tionshadasatisfactoryeffectontreatingthisdisease;anditcansignificantlyimprovetheclinicalsymptomsofthepatients.

简介：Objective:Toobservethetherapeuticeffectofround-sharpneedleforprolapseoflumbarintervertebraldisc.Methods:Atotalof80casesoflumbarintervertebraldiscprolapseweretreatedbypuncturingQihaishu(气海俞BL24),Guanyuanshu(关元俞BL26),etc.,withround-sharpneedle,onceeveryweek,continuouslyfor4sessions.Results:Afterthetreatment,ofthe80cases,56(70%)werecured,16(20%)improved,and8(10)%)failed,withaneffectiverateof90%.Conclusion:Round-sharpneedleworkswellinthetreatmentofprolapseoflumbarintervertebraldisc.

简介：无

简介：选择腰椎间盘突出症后凸型患者96例，随机分为观察组50例和对照组46例，观察组采用针剌牵引推拿综合治疗，对照组仅用针刺治疗，对患者治疗后进行疗效评定。治疗组和对照组治疗后的疗效有显著差异(P<0．05)。综合治疗腰椎间盘突出症后凸型疗效确切，方法简便，具有一定的临床指导意义。

简介：150casesofprolapseoflumbarintervetebraldiscwererandomlydividedintotreatmentandcontrolgroups.80casesintreatmentgroupweretreatedwithcombinationofacupuncture,oraladministrationofChinesemedicinalherbs,traction,point-injectionandintravenousdripofenergydehydrationmixture;70casesincontrolgroupweremanagedbycombinationofacupuncture,oraladministrationofherbalmedicines,traction,acupoint-injection(withoutenergydehydrationmixture).Theresultsshowedthatthecurativerateandthetotaleffectiverateofthetreatmentgroupwere91.25%and98.75%separately,whilethoseofthecontrolgroup62.86%and92.86%respectively.Comparisonofthecurativeratebetweenthe2groupsshowedaremarkablesignificance(P＜0.01).TheobservationdemonstratedthatcombinedtreatmentofprolapseoflumbarintervertebraldiscwithtraditionalChineseandWesternmedicineisaneffectiveapproach.

简介：Objective:Toobservethetherapeuticeffectofcomprehensiveplum-blossommagneticneedletherapyonprolapseoflumbarintervertebraldisc.Methods:247casesofprolapseoflumbarintervertebraldiscweretreatedfirstwithmanualtreatmentandthenwithplum-blossommagneticneedletherapyandeffect-increasingpadtherapyatspecifiedpointsandreactivepoints.Results:Aftertreatmentfor2therapeuticcourses,153caseswerecuredaccountingfor61.94%,71casesweremarkedlyeffectiveaccountingfor28.75%,22caseswereimprovedaccountingfor8.91%andtherestonefailed,accountingfor0.45%.Conclusion:Thecomprehensiveplum-blossommagneticneedletherapyhasabettertherapeuticeffectonprolapseoflumbarintervertebraldisc.

简介：BackgroundChordaereconstructionisoneofthekeypointsinrepairofmitralvalveprolapse,especiallyforanteriorleaflets.Hereweintroduceourexperiencesofusingecho-determinednormalchordaellengthtomaketheloopspreoperativelyandrebuildtheelongated/rupturedchordaeintraoperatively.MaterialsandmethodFromJune2011toFebruary2012,19consecutivecaseswithmitralanteriorleafletprolapseunderwentvalverepairprocedures.Echocardiographywasusedtodeterminethelengthofnormalchordaethattheprolapsedleafletsshouldhavefornormalcoaptation.Theartificialchordaewasfabricatedinloopsaccordingtoecho-determinedlength.ResultsAllpatientssurvivedtheoperations.2.8preoperativelypreparedloopswereusedperpatienttorestoretheanteriorleaflets,aswellasposteriorleaflets.Artificialmitralvalveringswereappliedto18patientsformitralannuloplasty.16patientswereunderwentdifferentconcomitantoperations.Echocardiographicresultsatdischargeshowedthatgradeofmitralregurgitation,leftventricularend-diastolic,end-systolicdimensiondecreaseddefinitely,respectivelyfrom3.26±1.10,53.79±15.03mm,33.00±12.05mmpreoperativelyto0.47±0.61(P<0.01),44.74±10.28mm(P<0.01),30.16±10.58mm(P<0.05)postoperatively.AllpatientsimprovedclinicallyandNYHAfunctionalclassdecreasedsignificantlyfrom2.17±0.81to1.12±0.33.ConclusionReconstructionofprolapsedanteriorleafletchordaewithartificialloopsinpreoperativelyecho-determinedlengthissafeandeffective,andinitialclinicaloutcomeissatisfactory.

简介：AbstractBackground:It has been a global trend that increasing complications related to pelvic floor surgeries have been reported over time. The current study aimed to outline the development of Chinese pelvic floor surgeries related to pelvic organ prolapse (POP) over the past 14 years and investigate the potential influence of enhanced monitoring conducted by the Chinese Association of Urogynecology since 2011.Methods:A total of 44,594 women with POP who underwent pelvic floor surgeries between October 1, 2004 and September 30, 2018 were included from 22 tertiary academic medical centers. The data were reported voluntarily and obtained from a database. We compared the proportion of each procedure in the 7 years before and 7 years after September 30, 2011. The data were analyzed by performing Z test (one-sided).Results:The number of different procedures during October 1, 2011-September 30, 2018 was more than twice that during October 1, 2004-September 30, 2011. Regarding pelvic floor surgeries related to POP, the rate of synthetic mesh procedures increased from 38.1% (5298/13,906) during October 1, 2004-September 30, 2011 to 46.0% (14,107/30,688) during October 1, 2011-September 30, 2018, whereas the rate of non-mesh procedures decreased from 61.9% (8608/13,906) to 54.0% (16,581/30,688) (Z = 15.53, P < 0.001). Regarding synthetic mesh surgeries related to POP, the rates of transvaginal placement of surgical mesh (TVM) procedures decreased from 94.1% (4983/5298) to 82.2% (11,603/14,107) (Z = 20.79, P < 0.001), but the rate of laparoscopic sacrocolpopexy (LSC) procedures increased from 5.9% (315/5298) to 17.8% (2504/14,107).Conclusions:The rate of synthetic mesh procedures increased while that of non-mesh procedures decreased significantly. The rate of TVM procedures decreased while the rate of LSC procedures increased significantly.Trial registration number:NCT03620565, https://register.clinicaltrials.gov.